Volufiline is a trademarked topical plumping ingredient, not injectable filler, and the evidence that it can add facial volume is modest and mostly supplier-led. If you have just seen "filler in a bottle" on TikTok, or a Volufiline spray or a medicube "volufiline stick," that is the short answer. This page decodes what it is made of, what the much-quoted study actually showed, how it differs from hyaluronic acid, PDRN, and peptides, and which Mirai Skin products genuinely contain it. Mirai sells some of the Korean products named here.
What Volufiline actually is
Volufiline is a trademarked cosmetic active made by Sederma, part of Croda, and sold to brands for serums, sprays, balms, and creams — not a finished cream on its own. The blend is hydrogenated polyisobutene, an emollient oil, plus a root extract from the plant Anemarrhena asphodeloides, whose notable compound is sarsasapogenin. Brands market it as a way to help treated areas look slightly fuller by supporting lipid storage in fat cells.
On an ingredients list you will often see those two INCI names rather than the trade name, so a product can contain Volufiline without saying so on the pack.
Vogue has reported that the raw material is designed to be used at about 2 to 5% in a finished formula, and has warned shoppers not to buy "100% pure Volufiline" oils. Croda's public product page, as of this draft, still lists applications as body care, leg care, and silhouette sculpture — not face.
Does "filler in a bottle" skincare actually plump skin?
It helps to separate three things: laboratory work on cultured fat cells, the small in-vivo study everyone quotes, and what a cream can do on the surface through hydration and emollients.
What the published evidence actually shows
The supplier has published in-vitro work on adipocytes in cell culture — real, but still a long way from a face.
The figure that gets repeated comes from a small Sederma study. As GQ reported in November 2026, 28 women applied a cream containing Volufiline to one breast for 56 days. The treated breast's average volume increased by 2.2%, a change that was not statistically significant. The comparison was the untreated breast, not a placebo cream, so it is unclear whether Volufiline or other ingredients in the formula drove the change. Marie Claire has described that study cream as 5% Volufiline; GQ's account does not specify the percentage, and Croda's public product page does not publish the protocol.
This was not a facial trial. We did not find a strong, independent, peer-reviewed randomized trial showing that a topical meaningfully increases facial fat. Supplier brochures and patents are not that proof.
What people may still notice
A well-made cream, spray, or balm can still make skin look softer, smoother, and temporarily fuller, because it hydrates and changes how light reflects off the surface. Dermatologists quoted in GQ and Allure have said this plainly: that is not the same as rebuilding the fat underneath. Any effect, if you notice one at all, may be mild and gradual. Results vary. We are not publishing before-and-afters or inventing an "8 to 12 week clinical window."
Volufiline vs filler, vs hyaluronic acid, vs PDRN and peptides
Injectable filler is placed under the skin in a chosen tissue plane and can reshape an area right away. A cream, spray, or balm stays on the surface and cannot reliably restore lost facial volume or lift tissue.
Hyaluronic acid helps skin look plump by holding water near the surface — a hydration effect, not a change in fat cells. PDRN and peptides are different mechanisms again: repair signalling and collagen signalling, already covered in those guides. Volufiline's claimed mechanism is lipid storage in fat cells. Whether a leave-on cosmetic reaches subcutaneous fat at an effective dose is still an open question.
How to use it in a K-routine (and who should be careful)
If you are using a serum or spray, apply it on clean skin after toner, then moisturize. A cream can be the moisturizing step. A targeted balm can be swept over small areas, such as under-eyes, smile lines, or lips, if the pack allows it. Patch-test first, especially if your skin is acne-prone, oily, very sensitive, or if you have eczema or rosacea. Many Volufiline formulas are oil-heavy, and that carrier can bother some skin. Do not use raw "100% Volufiline" oils. We are not offering pregnancy or medical advice. If volume loss is the real concern, a topical is not a reason to skip a dermatologist.
Which Mirai products actually use it (10 November 2026, Asia/Nicosia)
Only the products below are named here. Recheck stock on the product page before you buy; we have not locked a price. A "volume," "tox," or Reedle label is not enough on its own.
The d'Alba Intensive Volufiline Spray Ampoule 50ml is named for the ingredient and was in stock on 10 November 2026, though stock was very low. Check the page again at checkout, or browse the d'Alba collection.
The medicube PDRN Pink Collagen Volume Multi Balm 10g is the stick many people mean by a "medicube volufiline stick." It is not a sunscreen stick. medicube's official US page names Volufiline as a key ingredient, and its INCI list includes both hydrogenated polyisobutene and Anemarrhena asphodeloides root extract. Allure has credited the balm with 5% Volufiline; we could not confirm that percentage on the official US list or on Mirai's product page, so we are not stating 5% as a fact. It was in stock at this check.
MEDIPEEL Peptide 9 Volume & Tension Tox Cream Pro 50g is a softer mention, not a hero Volufiline product. The official Australian INCI lists both constituents, but Anemarrhena asphodeloides root extract sits very far down the list, among trace peptides, so this is not a dedicated 5% formula. The "Full Ingredients" block on the Mirai product page is a highlights list, not a complete INCI. It was in stock at this check.
The d'Alba Intensive Volufiline Grinding Cream 45g is named for the ingredient, but it was out of stock on 10 November 2026. Use the product page for a restock notice; we do not have a date to share. The anti-aging collection is a broader starting point; not every "volume" product contains Volufiline.
FAQ
What is Volufiline?
Volufiline is a trademarked cosmetic ingredient made by Sederma (part of Croda), not a finished cream on its own. It is a blend of hydrogenated polyisobutene, an emollient oil, and a root extract from the plant Anemarrhena asphodeloides, which contains the compound sarsasapogenin. Brands use it in serums, sprays, and balms and market it as a way to help treated areas look slightly fuller by supporting lipid storage in fat cells. An ingredients list will often show those two INCI names rather than the trade name Volufiline.
Does "filler in a bottle" skincare actually plump skin?
Not in the way the phrase suggests. The best-known supplier study asked 28 women to apply a Volufiline cream — described in some coverage, including Marie Claire, as a 5% formula — to one breast for 56 days, and reported a 2.2% average volume increase. That change was not statistically significant, and the comparison was an untreated breast rather than a placebo cream. That is not a facial trial, and independent peer-reviewed evidence that a topical meaningfully increases facial fat is still lacking. A good formula can still make skin look softer and temporarily plumper through hydration and emollients; that is a cosmetic surface effect, not rebuilt volume.
Is Volufiline a replacement for filler?
No. Injectable filler is placed under the skin in a controlled plane and can add structure or reshape an area right away. A cream, spray, or balm stays on the surface, works gradually if it works at all, and cannot reliably restore lost facial volume or lift tissue. At most, Volufiline is an optional cosmetic step for someone who wants a modest, realistic plump-looking finish and understands the evidence is limited. It is not a clinic treatment in a bottle, and not a reason to skip professional advice if volume loss is the real concern.
